Casdin Capital, LLC Dyne Therapeutics, Inc. Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $9.72 Million - $13.6 Million	-610,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $3.36 Million - $7.03 Million	240,000 Added 64.86%	610,000 $9.47 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $7.4 Million - $8.84 Million	370,000 New	370,000 $7.47 Million

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.27B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.